Pharmaceutical solid dosage form
US8685448B2 · kind B2 · utility
4Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2010 |
| Grant date | Apr 1, 2014 |
| Priority date | — |
| Expiry date | Nov 5, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a solid dosage form comprising (i) a core comprising a benzimidazole; (ii) a separating layer comprising a water soluble polymer and glyceryl monostearate; and (iii) an enteric coating.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.